AstraZeneca Pulls Covid Vaccine Globally
Facing scrutiny over rare blood clot concerns, AstraZeneca pharmaceutical company has opted to withdraw its COVID-19 vaccine from markets worldwide, citing diminished demand in favor of other options.
Loading...
Facing scrutiny over rare blood clot concerns, AstraZeneca pharmaceutical company has opted to withdraw its COVID-19 vaccine from markets worldwide, citing diminished demand in favor of other options.
Four years after the first serious cases of pneumonia emerged in Wuhan in December 2019, nearly 7 million people have died from COVID-19, and nearly 65 million are still struggling with the mysterious effects of the infection. A syndrome called long-term corona.